Yahoo
Stuttgart - Delayed Quote EUR

NurExone Biologic Inc (J90.SG)

0.2940 -0.0020 (-0.68%)
As of 8:48:40 AM GMT+1. Market Open.
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0 0 0 0 0
Selling, General and Administrative Expenses
-3,500 -3,653 -3,111 -2,095 -4,136
Research and Development Expenses
-2,700 -2,637 -1,868 -1,541 -1,391
Depreciation, Amortization and Depletion
-33 -33 -30 -21 -14
Operating Income/Expenses
-6,233 -6,323 -5,009 -3,657 -5,541
Total Operating Profit/Loss
-6,233 -6,323 -5,009 -3,657 -5,541
Total Net Finance Income/Expense
-32 -17 30 42 -18
Net Investment Income
-49 -49 -23 -2 -466
Irregular Income/Expenses
-- -- -- 0 -2,078
Other Income/Expense, Non-Operating
5 5 -42 -22 -66
Non-Operating Income/Expenses, Total
-76 -61 -35 18 -2,628
Pretax Income
-6,309 -6,384 -5,044 -3,639 -8,169
Net Income from Continuing Operations
-6,309 -6,384 -5,044 -3,639 -8,169
Net Income after Extraordinary Items and Discontinued Operations
-6,309 -6,384 -5,044 -3,639 -8,169
Net Income after Non-Controlling/Minority Interests
-6,309 -6,384 -5,043 -3,639 -8,169
Net Income Available to Common Stockholders
-6,309 -6,384 -5,043 -3,639 -8,169
Diluted Net Income Available to Common Stockholders
-6,309 -6,384 -5,043 -3,639 -8,169
Basic EPS
-0.08 -0.08 -0.08 -0.08 -0.22
Diluted EPS
-0.08 -0.08 -0.08 -0.08 -0.22
Basic Weighted Average Shares Outstanding
87,825.3720 80,015.0400 65,417.2890 44,722.2880 37,733.7030
Diluted Weighted Average Shares Outstanding
87,825.3720 80,015.0400 65,417.2890 44,722.2880 37,733.7030
Income Statement, Supplemental
EBIT
-6,277 -6,367 -5,074 -3,636 -8,136
EBITDA
-6,062 -6,182 -4,989 -3,603 -8,130
Normalized EBITDA
-4,488 -4,892 -4,054 -2,964 -5,381
Normalized Income
-4,735 -5,094 -4,109 -3,000 -5,420
Total Unusual Items
1,574 1,290 935 639 2,749
Total Unusual Items Excluding Goodwill
1,574 1,290 935 639 2,749
Tax Effect of Unusual Items
0 0 0 0 0
Tax Rate, Calculated
0.00 0.00 0.00 0.00 0.00
12/31/2022 - 9/12/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: